Drugmakers pressured with Trump tariffs after price‑cut talks faltered
NegativeFinancial Markets

Drugmakers are facing increased pressure due to tariffs imposed by the Trump administration after negotiations for price cuts stalled. This situation is significant as it highlights the ongoing struggle between pharmaceutical companies and government efforts to make medications more affordable for consumers. The tariffs could lead to higher costs for drug manufacturers, potentially impacting the prices patients pay at the pharmacy.
— Curated by the World Pulse Now AI Editorial System